Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

Objectives/methods: This 1-yr prospective phase II trial evaluated the efficacy of deferasirox in regularly transfused patients aged 3-81 yrs with myelodysplastic syndromes (MDS; n = 47), Diamond-Blackfan anaemia (DBA; n = 30), other rare anaemias (n = 22) or beta-thalassaemia (n = 85). Dosage was determined by baseline liver iron concentration (LIC). Results: In patients with baseline LIC >= 7 mg Fe/g dry weight, deferasirox initiated at 20 or 30 mg/kg/d produced statistically significant decreases in LIC (P < 0.001); these decreases were greatest in MDS and least in DBA. As chelation efficiency and iron excretion did not differ significantly between disease groups, the differences in LIC changes are consistent with mean transfusional iron intake (least in MDS: 0.28 +/- 0.14 mg/kg/d; greatest in DBA: 0.4 +/- 0.11 mg/kg/d). Overall, LIC changes were dependent on dose (P < 0.001) and transfusional iron intake (P < 0.01), but not statistically different between disease groups. Changes in serum ferritin and LIC were correlated irrespective of disease group (r = 0.59), supporting the potential use of serum ferritin for monitoring deferasirox therapy. Deferasirox had a safety profile compatible with long-term use. There were no disease-specific safety/tolerability effects: the most common adverse events were gastrointestinal disturbances, skin rash and non-progressive serum creatinine increases. Conclusions: Deferasirox is effective for reducing iron burden with a defined, clinically manageable safety profile in patients with various transfusion-dependent anaemias. There were no disease-specific adverse events. Once differences in transfusional iron intake are accounted for, dose-dependent changes in LIC or serum ferritin are similar in MDS and other disease groups

Françoise Kourilsky, le théâtre aux Etats-Unis

info:eu-repo/semantics/publishe

Biennale de l'Association européenne des études américaines, Bordeaux, 22-25 mars 2002

Debusscher Gilbert. Biennale de l'Association européenne des études américaines, Bordeaux, 22-25 mars 2002. In: Bulletin de la Classe des lettres et des sciences morales et politiques, tome 14, n°1-6, 2003. pp. 277-279

Le 11e festival de littérature Tenessee Williams à la Nouvelle Orléans, 20-23 mars 1997

Debusscher Gilbert. Le 11e festival de littérature Tenessee Williams à la Nouvelle Orléans, 20-23 mars 1997. In: Bulletin de la Classe des lettres et des sciences morales et politiques, tome 8, n°7-12, 1997. pp. 559-562

Pratique de l'anglais contemporain II

5e édition 1993-1994/1Documents destinés aux étudiants de seconde candidature en Journalisme et Communicationinfo:eu-repo/semantics/published

English Poetry from the Beginning to the Romantic Period

SYL-2543 = fascicule 1 ;SYL-2544 = fascicule 2Fascicule 2 :finEdition 1977-1978Fascicule 2 n'a pas été exécutée par les Presses Universitaires de Bruxelles1e et 2e candi. Philo. Germ.info:eu-repo/semantics/publishe

History of English Literature II: Historical Survey of English Poetry

SYL-060 = Volume I ;SYL-061 = Volume IIVolume I :English Poetry :From Antiquity to the End of the Romantic Period1re édition 1992-1993/12e candid. germ. langues et linguistiqueinfo:eu-repo/semantics/published

Conférence biennale de EAAS (European Association of American Studies), à Prague du 2 au 5 avril 2004

Debusscher Gilbert. Conférence biennale de EAAS (European Association of American Studies), à Prague du 2 au 5 avril 2004. In: Bulletin de la Classe des lettres et des sciences morales et politiques, tome 15, n°7-12, 2004. pp. 497-499

Educating Rita or, an Open University Pygmalion

info:eu-repo/semantics/publishe

Pratique de l'anglais contemporain I

INFJOU1, INFLIV - GERM004info:eu-repo/semantics/published1